Overview

Tonabersat in the Prophylaxis of Migraine With Aura

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
Overall trial objectives: 1. Can treatment with tonabersat reduce the number of days with aura and/or migraine headache in patients with migraine with aura 2. How well tolerated is treatment with tonabersat The study is based on the hypothesis that the unique mechanism of action of tonabersat will inhibit some of the early events in the generation of aura and migraine headache and so be effective as prophylactic treatment
Phase:
Phase 2
Details
Lead Sponsor:
Minster Research Ltd
Collaborator:
University of Copenhagen